The rebuke came in response to an expert panel convened by the FDA to discuss the cornucopia of evidence that SSRIs don’t actually treat depression.
The rebuke came in response to an expert panel convened by the FDA to discuss the cornucopia of evidence that SSRIs don’t actually treat depression.